Targeting Inflammation Using Salsalate for Type 2 Diabetes-Stage II

NCT00799643 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

638

Enrollment

OTHER

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: Salsalate
DRUG: Salsalate Placebo

Sponsor

Joslin Diabetes Center

Collaborators

[object Object]